Clinical Trial Update: Comparative Study of Micafungin (FK463) Versus Placebo as Prophylactic Antifungal Therapy in the ICU [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing micafungin (FK463) to placebo for prophylaxis of invasive fungal infections in ICU patients; the study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Fungal Infections

Drugs mentioned

• Micafungin (micafungin)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Invasive Fungal Infections | Phase 3 | Status: TERMINATED